ProCE Banner Activity


Advances in MASLD/MASH Therapeutics and Updates to the Development Pipeline

Text Module

Join Mazen Noureddin, MD, MHSc, as he covers current treatments, advances, and future therapies in the field of MASLD/MASH.

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurses: 0.50 Nursing contact hour

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Released: March 13, 2024

Expiration: March 12, 2025



Mazen Noureddin

Mazen Noureddin, MD, MHSc

Professor of Medicine
Houston Methodist Hospital
Houston Research Institute
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC, in partnership with the American Gastroenterological Association (AGA) and Practicing Clinicians Exchange (PCE).

ProCE Banner


Supported by an educational grant from Novo Nordisk.

Novo Nordisk



ProCE Banner

Practicing Clinicians Exchange

ProCE Banner

Target Audience

Physicians—including residents and fellows—nurse practitioners, and physician associates/physician assistants practicing in gastroenterology, hepatology, endocrinology, and primary care who manage individuals with or at risk for MASLD/MASH.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Nonalcoholic Steatohepatitis (NASH).

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Analyze current treatment options for patients with MASLD/MASH

  • Summarize the latest efficacy and safety data on emerging treatments for MASLD/MASH


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Mazen Noureddin, MD, MHSc

Professor of Medicine
Houston Methodist Hospital
Houston Research Institute
Houston, Texas

Mazen Noureddin, MD, MHSc: consultant/advisor/speaker: 89Bio, Altimmune, BI, Corecept, Cytodyn, GlaxoSmithKline, Madrigal, Merck, Northsea, Novo Nordisk, Takeda, Terns; researcher: Akero, Allergan, BI, Bristol-Myers Squibb, Conatus, Corcept, Enanta, Galectin, Genfit, Gilead, GlaxoSmithKline, Madrigal, Novartis, Novo Nordisk,  Shire, Takeda, Terns, Viking and Zydus; individual publicly traded stock/stock options: ChronWell, CIMA, Cytodyn, Rivus Pharma.

The planners and content peer reviewers from Clinical Care Options, LLC, the American Gastroenterological Association (AGA), and Practicing Clinicians Exchange (PCE) do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 13, 2024, through March 12, 2025:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.


This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours.

Physician Associate Continuing Medical Education

LogoDescription automatically generated

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until March 12, 2025. PAs should only claim credit commensurate with the extent of their participation.